Benzergoline

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBenzergoline
Drug Alias NameCY-208-243CY-208243
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor agonists
TargetsDopamine D1 receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A